Munich, Germany

Sandra Miller

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Sandra Miller in Biomedicine**

Introduction

Sandra Miller is an accomplished inventor based in Munich, Germany. With a remarkable portfolio of three patents, she has made significant strides in the field of biomedicine, particularly focusing on antibodies that have critical therapeutic and diagnostic implications. Her innovative work demonstrates a strong commitment to advancing medical science and improving treatment options for complex disorders.

Latest Patents

Among her notable patents, two stand out for their potential impact on cancer treatment and osteoporosis management. The first patent, titled "Anti-MST1R antibodies and uses thereof," involves recombinant antigen-binding regions and antibodies specific for MST1R, which is integral to various disorders, including cancer. These antibodies provide promising avenues for treating such conditions, as well as serving diagnostic purposes and furthering the understanding of MST1R's role in tumor progression.

Her second patent, "Antibody targeting osteoclast-related protein Siglec-15," describes an isolated antibody designed to inhibit osteoclast formation and bone resorption. The antibody is characterized by specific sequences of its heavy and light chains, offering a targeted approach for managing conditions associated with bone health. These patents reflect her innovative spirit and dedication to tackling pressing medical challenges.

Career Highlights

Sandra's career has been shaped by her work with leading companies, including Daiichi Sankyo Company and Hoffmann-La Roche Inc. These experiences have provided her with the expertise and resources to drive her innovative projects. Her extensive background in pharmaceutical development has positioned her at the forefront of biotechnological advancements.

Collaborations

Throughout her career, Sandra has collaborated with talented individuals in the field, including Toshiaki Ohtsuka and Toshinori Agatsuma. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment that encourages innovation and the pursuit of groundbreaking research.

Conclusion

In conclusion, Sandra Miller's contributions to the field of biomedicine through her patents and collaborative efforts highlight her role as a leading inventor. Her work not only paves the way for new treatment modalities but also exemplifies the importance of innovation in addressing complex health issues. As she continues to push the boundaries of science, her impact will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…